BACKGROUND: parenteral zanamivir is a promising drug for the treatment of severe influenza. However, quantification of this polar drug in biological matrices has traditionally been difficult and the methods developed have been relatively insensitive. RESULTS: a high-throughput bioanalytical method for the analysis of zanamivir in human plasma using SPE in the 96-well plate format and LC coupled to positive MS/MS has been developed and validated according to US FDA guidelines. The method uses ...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Quantification of the anti-influenza drug zanamivir in plasma using high-throughput HILIC-MS/MS.
If you are the owner of this record, you can report an update to it here: Report update to this record